Related Experiment Videos
Spinal cord astrocytoma: response to PCV chemotherapy
J W Henson1, A F Thornton, D N Louis
1Brain Tumor Center, Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA. henson@helix.mgh.harvard.edu
Neurology
|February 11, 2000
Abstract:
Information regarding the value of chemotherapy for spinal cord astrocytomas that progress after irradiation is limited. We describe a patient whose conus medullaris astrocytoma responded to PCV (procarbazine, lomustine, and vincristine) chemotherapy after failing radiation and cisplatin-based chemotherapy. PCV should be considered in patients with progressive spinal cord astrocytomas.